Main Menu
Menu

March-in Rights

Publish Date
Resources
Letters
Former Commerce Officials Letter to President Biden RE: March-in Rights
Council for Innovation Promotion
News
The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows
IPWatchdog
Joe Allen
BlogFact Checks
Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices

Claim: On December 7, the Biden administration proposed a policy framework claiming a newfound authority, under the 43-year-old Bayh-Dole Act, to rescind...

Council for Innovation Promotion
Op-Eds
Biden’s Bayh-Dole Act proposal misuses ‘march-in rights’
Detroit News
Judge Paul Michel ret. and Judge Kathleen O 'Malley ret.
News
Proposed ‘price’ criteria for march-in rights poses threat to U.S. innovation, critics say
Tech Transfer Central
Technology Transfer Tactics
BlogOp-Eds
President Biden’s domestic technology seizure plan

Over the weekend, C4IP Co-Chairs and former USPTO Directors David Kappos and Andrei Iancu published an opinion piece in The Hill detailing...

The Hill
Andrei Iancu and David Kappos
Op-Eds
White House’s Drug Patent Plan Undercuts Research and Innovation

Merrill Matthews, a resident scholar with the Institute for Policy Innovation, recently published an opinion piece in RealClearHealth calling attention to the...

Bloomberg Law
Paul Michel and Kathleen O 'Malley
News
From AI to Amgen, Here’s Everything IP that Mattered in 2023

Another year of IP is behind us, and it is time to reflect on what mattered most—what decisions will affect practice for...

IPWatchdog
Eileen McDermott
Resources
Issue Briefs
The Bayh-Dole Act and March-In Rights

On December 7, 2023, the Biden administration released a request for information (RFI) regarding an unprecedented proposal for the government to take...

Council for Innovation Promotion
News
Biden Drug Patent Seizures Would Test Scope of Government Power
Bloomberg Law
Ian Lopez
Press Releases
Council for Innovation Promotion Board Members’ Statement on Administration’s Proposed Patent Abuse

WASHINGTON (December 8, 2023) — Today, C4IP Board Members and former Federal Circuit Court Judges Kathleen O’Malley and Paul Michel issued the...

Council for Innovation Promotion
News
Proposed Framework on March-In Rights Dubbed ‘Unprecedented’ by U.S. Chamber
IPWatchdog
Eileen McDermott
Resources:

Resources:

Former Commerce Officials Letter to President Biden RE: March-in Rights,

02/02/2024
News:

News:

The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows,

01/29/2024
Blog:

Blog, Fact Checks:

Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices,

01/29/2024
Op-Eds:

Op-Eds:

Biden’s Bayh-Dole Act proposal misuses ‘march-in rights’,

01/25/2024
Videos:

Videos:

Briefing on the Bayh-Dole Act and March-In Rights,

01/24/2024
News:

News:

Proposed ‘price’ criteria for march-in rights poses threat to U.S. innovation, critics say,

01/23/2024
Op-Eds:

Blog, Op-Eds:

President Biden’s domestic technology seizure plan,

01/14/2024
Op-Eds:

Op-Eds:

White House’s Drug Patent Plan Undercuts Research and Innovation,

01/09/2024
News:

News:

From AI to Amgen, Here’s Everything IP that Mattered in 2023,

12/24/2023
Resources:

Resources:

The Bayh-Dole Act and March-In Rights,

12/08/2023
News:

News:

Biden Drug Patent Seizures Would Test Scope of Government Power,

12/08/2023
Press Releases:

Press Releases:

Council for Innovation Promotion Board Members’ Statement on Administration’s Proposed Patent Abuse,

12/08/2023
Scroll to Top